Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TCDA

Tricida (TCDA) Stock Price, News & Analysis

Tricida logo

About Tricida Stock (NASDAQ:TCDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.11
$0.19
52-Week Range
N/A
Volume
31.13 million shs
Average Volume
17.62 million shs
Market Capitalization
$6.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.

Receive TCDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter.

TCDA Stock News Headlines

Patrick G Enright's Net Worth
The one deadline Elon can't afford to miss...
For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for it: "Elon Time." But this time... it’s different. A fleet of autonomous robotaxis is scheduled to be unleashed on the streets of Austin, Texas, this June.
Tricida Inc (TCDAQ)
Firm Retention Summary: Tricida Inc.
Tricida Announces Third Quarter 2022 Financial Results
Tricida Provides Strategic Update
See More Headlines

TCDA Stock Analysis - Frequently Asked Questions

Tricida, Inc. (NASDAQ:TCDA) announced its quarterly earnings data on Monday, November, 8th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.70) by $0.09.

Tricida (TCDA) raised $175 million in an initial public offering (IPO) on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tricida investors own include Sorrento Therapeutics (SRNE), Alibaba Group (BABA), NIO (NIO), Pfizer (PFE), Energy Transfer (ET), Teladoc Health (TDOC) and Sesen Bio (SESN).

Company Calendar

Last Earnings
11/08/2021
Today
5/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TCDA
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$176.57 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
35,851,000
Market Cap
$6.01 million
Optionable
Not Optionable
Beta
0.22
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:TCDA) was last updated on 5/30/2025 by MarketBeat.com Staff
From Our Partners